Dr. rer. nat. Andreas Puyskens is an immunologist and researcher based in Berlin working at the Center For Biological Threats And Special Pathogens (ZBS) at the Robert Koch Institute. Member of the Global Virus Network (GVN), European Mobile Lab (EMLab), and a nominated qualified expert for the UN Secretary-General’s Mechanism for Investigation of Alleged Use of Chemical or Biological Weapons (UNSGM).
Github
ORCID
PubMed
LinkedIn
ResearchGate
Projects:
2026 – ongoing: RESILIENCE-RA-2024: Multiplex Rapid Point of Care Diagnostic Tests for Biological Agents and Toxins (European Defense Fund)
2023 – 2025: ISO-BT: Isothermal Amplification-Based Diagnostic Platform for the Detection of Bioterror Agents (Federal Ministry of Health Germany)
2023 – 2025: Global Health Protection Programme (GHPP): IDEAnet: Network for the Identification of Emerging Agents in Sri Lanka (Federal Ministry of Health Germany)
2021-2022: Global Health Protection Programme (GHPP): IDEA: Identification of Emerging Agents. Strengthening Diagnostic Capacities in Sri Lanka (Federal Ministry of Health Germany)
2022: German Biosecurity Programme. Biosafety Trainings in Tunisia (German Federal Foreign Office)
2021: German Biosecurity Programme. Capacity Building in Sudan (German Federal Foreign Office)
2021: German Epidemic Preparedness Team (SEEG). SARS-CoV-2 response Mauretania
Upcoming conference engagements:
tba
Past conference engagements:
CSR Berlin Biosecurity Dialogue – June 19-20, 2025
Medical Biodefense Conference 2025 – April 4-10, 2025
Fellowships:
Council on Strategic Risks (CSR)
Networks:
Global Virus Network (GVN)
Publications:
2026: Dual read-out RT-LAMP for the detection of Bundibugyo Ebolavirus (BDBV) based on Oloniniyi et al. 2017 (RKI)
2026: RNase HII-assisted amplification (RHAM) for rapid point-of-care monkeypox detection pre-print (MedRxiv)
2023: Results of German external quality assessment schemes for SARS-CoV-2 antigen detection (Scientific Reports)
2023: Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic (Virology Journal)
2023: Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron (Journal of Clinical Virology)
2023: Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany (Eurosurveillance)
2022: Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event (BMJ Global Health)
2021: Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs (Frontiers in Medicine)
2021: Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance)
2021: Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance)
2021: Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 (Virology Journal)
2021: Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19 (Molecular and Cellular Probes)
2020: Aryl Hydrocarbon Receptor Modulation by Tuberculosis Drugs Impairs Host Defense and Treatment Outcomes (Cell Host & Microbe)
2019: Host monitoring of quorum sensing during Pseudomonas aeruginosa infection (Science)
2019: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (Scientific Reports)
2017: Distribution and Activation of CD8+ T Cells in the Duodenal Mucosa before and after HIV Seroconversion (Journal of Immunology)
2015: RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection (Journal of Immunology)